First-in-human (FIH) Safety and Dose Ranging Study of TT-034 in Patients with Chronic Hepatitis C (CHC) Infection
Clinical Trial Grant
Awarded By
Tacere Therapeutics
Start Date
January 2, 2014
End Date
November 6, 2019
Awarded By
Tacere Therapeutics
Start Date
January 2, 2014
End Date
November 6, 2019